Venlafaxine and paroxetine in treatment-resistant depression - Reply

被引:0
|
作者
Poirier, MF
Boyer, P
机构
[1] CHU St Anne, SHU, F-75674 Paris, France
[2] Hop La Pitie Salpetriere, Paris, France
关键词
D O I
10.1192/S0007125000263526
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:591 / 591
页数:1
相关论文
共 50 条
  • [1] Venlafaxine and paroxetine in treatment-resistant depression
    Gregson, J
    BRITISH JOURNAL OF PSYCHIATRY, 1999, 175 : 591 - 591
  • [2] Venlafaxine and treatment-resistant depression
    Thase, ME
    Friedman, ES
    Howland, RH
    DEPRESSION AND ANXIETY, 2000, 12 : 55 - 62
  • [3] Venlafaxine and paroxetine in treatment-resistant depression - Double-blind, randomised comparison
    Poirier, MF
    Boyer, P
    BRITISH JOURNAL OF PSYCHIATRY, 1999, 175 : 12 - 16
  • [4] VENLAFAXINE FOR TREATMENT-RESISTANT UNIPOLAR DEPRESSION
    NIERENBERG, AA
    FEIGHNER, JP
    RUDOLPH, R
    COLE, JO
    SULLIVAN, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1994, 14 (06) : 419 - 423
  • [5] High doses of venlafaxine in treatment-resistant depression
    Abuzzahab, FS
    Kayongo, MN
    BIPOLAR DISORDERS, 2004, 6 : 35 - 35
  • [6] Olanzapine plus venlafaxine in treatment-resistant depression
    Devarajan, S
    Dursun, SM
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (04) : 434 - 435
  • [7] Defining Treatment-Resistant Depression Reply
    Conway, Charles R.
    George, Mark S.
    Sackeim, Harold A.
    JAMA PSYCHIATRY, 2017, 74 (07) : 759 - 759
  • [8] Psilocybin for Treatment-Resistant Depression Reply
    Goodwin, Guy M.
    Hellerstein, David J.
    Young, Allan H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (08):
  • [9] The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study
    Li, Xiaoyi
    Xing, Baoping
    Yu, Enyan
    Chen, Wei
    Wu, Hao
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (02) : 157 - 160
  • [10] Venlafaxine/mirtazapine-combination in treatment-resistant major depression
    Ullrich, H.
    Pach, J. L.
    Kudling, R.
    Klieser, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S329 - S330